Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
暂无分享,去创建一个
B. Choe | Rahyeong Juh | Jaesung Kim | Daehyuk Moon | Boyoung Choe | Tasuk Suh | R. Juh | Jaesung Kim | D. Moon | T. Suh
[1] W. Heiss,et al. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.
[2] T. Vogl,et al. Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism , 1999, Neuroradiology.
[3] Shozo Tobimatsu,et al. Cerebral metabolic changes in early multiple system atrophy: a PET study , 2002, Journal of the Neurological Sciences.
[4] Masanori Ichise,et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP , 2002, Movement disorders : official journal of the Movement Disorder Society.
[5] D. J. Brooks,et al. Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease , 2000, Journal of Neurology.
[6] Karl J. Friston,et al. Commentary and Opinion: II. Statistical Parametric Mapping: Ontology and Current Issues , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] R P Maguire,et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.
[8] T. Yen,et al. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] E. Broussolle,et al. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.
[10] F. Tison,et al. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.
[11] P. David Mozley,et al. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson’s disease , 1999, European Journal of Nuclear Medicine.
[12] K. Van Laere,et al. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[13] C. Good,et al. Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.
[14] N. Hashimoto,et al. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy , 2000, Journal of Neural Transmission.
[15] D J Brooks,et al. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[16] Y Ben-Shlomo,et al. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.
[17] Robert B. Innis,et al. [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy , 2001 .
[18] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[19] J R Moeller,et al. Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography , 1995, Neurology.
[20] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[21] C. Counsell,et al. Clinical usefulness of MRI in multisystem atrophy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[22] A. Bol,et al. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration , 1989, Annals of neurology.
[23] W. Poewe,et al. The differential diagnosis of Parkinson's disease. , 2002, European journal of neurology.
[24] Tetsuya Mori,et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration , 2002, Journal of the Neurological Sciences.
[25] Angelo Antonini,et al. Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism , 2002, Movement disorders : official journal of the Movement Disorder Society.
[26] Karl J. Friston,et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.